| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Tenaya Therapeutics (NASDAQ:TNYA) through any online brokerage.
Other companies in Tenaya Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Tenaya Therapeutics has a consensus price target of $5.60.
The stock price for Tenaya Therapeutics (NASDAQ: TNYA) is $0.4099 last updated October 14, 2026 at 7:57 PM EDT.
There are no upcoming dividends for Tenaya Therapeutics.
Tenaya Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Tenaya Therapeutics.
Tenaya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
